Joe Tragesser - Green Cures CEO
| GRCU Stock | USD 0.0002 0.0001 100.00% |
CEO
Mr. Joe Tragesser is no longer President, Chief Executive Officer of the Company., effective December 31, 2017. Joe brings with him more than three decades of worldclass consumer products experience. Joe impressive record attests to an empowering, professional leader with a strong focus on results, and who has consistently succeeded to turn around and ignite businesses and brands. Tragesser is an experienced food and beverage executive with over 35 years of senior leadership roles and an exceptional track record with some of the largest consumable products companies, as well as food and beverage distributers. Joe extensive background consists of 29 years with Hostess Brands as a District Sales Manager before becoming Vice President of Marketing and Director of Sales for BCU Food Brokers and currently serves as President for Continental Food Beverage Brokers, which is his own company. Joe extensive background consists of 29 years with Hostess Brands as a District Sales Manager before becoming Vice President of Marketing and Director of Sales for BCU Food Brokers and currently serves as President for Continental Food Beverage Brokers, which is his own company. Joe has also been involved with several beverage companies. Specifically Tea Aroma Maxpresso bringing them into Unified Southern California and reducing their distribution fees from 22 percent to 9 percent allowing them several new customers through both Unified and Kay Hee in Northern California. Tragesser is also the exclusive broker for Hard Rock Energy Drink in California, Nevada and Arizona. Du Be Energy Shot is a hemp infused energy shot, to which Continental Food Beverage Brokers and affiliates have the exclusive distribution rights to distribute in California in addition to export rights as well. Joe also has an association with Liquid Nitro Energy Drink and Shots, as well as Vittorio Coffee, which happens to be the number one coffee in Australia.
| Phone | 888-509-8085 |
| Web | https://greencurescorp.com |
Green Cures Management Efficiency
The company has return on total asset (ROA) of 0.023 % which means that it generated a profit of $0.023 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.5462 %, meaning that it created $0.5462 on every $100 dollars invested by stockholders. Green Cures' management efficiency ratios could be used to measure how well Green Cures manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 7 records | CEO Age | ||
| MD Huber | Mersana Therapeutics | 64 | |
| Anna Protopapas | Mersana Therapeutics | 53 | |
| Joseph Reilly | Provident Bancorp | 66 | |
| David Mansfield | Provident Bancorp | 62 | |
| Marc Voigt | Immutep Ltd ADR | 51 | |
| Martin MD | Mersana Therapeutics | 63 | |
| Guy Bernstein | Formula Systems 1985 | 56 | |
Management Performance
| Return On Equity | 0.55 | |||
| Return On Asset | 0.023 |
Green Cures Botanical Leadership Team
Elected by the shareholders, the Green Cures' board of directors comprises two types of representatives: Green Cures inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Green. The board's role is to monitor Green Cures' management team and ensure that shareholders' interests are well served. Green Cures' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Green Cures' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Aymar Yoboue, CFO | ||
| Joe Tragesser, CEO | ||
| Michael Lajtay, Chief Pres | ||
| Benjamin Craik, Chief Officer | ||
| Joseph Tragesser, Consultant Advisor | ||
| Rich Thomas, Chief Officer | ||
| David Moceri, Chief Officer | ||
| Jhasmin Santizo, Director | ||
| Wendy Osegueda, South and Central America Chief of Operations and Board Member | ||
| Meki Cox, CTO |
Green Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Green Cures a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.55 | |||
| Return On Asset | 0.023 | |||
| Profit Margin | 4.96 % | |||
| Operating Margin | 0.62 % | |||
| Current Valuation | 4.85 M | |||
| Price To Sales | 2.80 X | |||
| Revenue | 13.17 K | |||
| Gross Profit | 989.6 K | |||
| EBITDA | 861.7 K | |||
| Net Income | (1.09 M) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Green Cures in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Green Cures' short interest history, or implied volatility extrapolated from Green Cures options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Green Cures Botanical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Green Cures Botanical information on this page should be used as a complementary analysis to other Green Cures' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Complementary Tools for Green Pink Sheet analysis
When running Green Cures' price analysis, check to measure Green Cures' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Green Cures is operating at the current time. Most of Green Cures' value examination focuses on studying past and present price action to predict the probability of Green Cures' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Green Cures' price. Additionally, you may evaluate how the addition of Green Cures to your portfolios can decrease your overall portfolio volatility.
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets |